Date published: 2025-10-11

1-800-457-3801

SCBT Portrait Logo
Seach Input

Josephin-3 Activators

The chemical class of potential TAF1D activators primarily consists of compounds that influence transcriptional regulation, particularly affecting RNA polymerase I activity and chromatin structure. These activators work by various mechanisms, such as intercalation into DNA, inhibition of transcription initiation, and modification of chromatin structure. For instance, Triptolide and Actinomycin D, both known for their potent effects on RNA polymerase, could indirectly modulate TAF1D's activity in the RNA polymerase I complex. Similarly, epigenetic modifiers like JQ1, RGFP966, Vorinostat, and Trichostatin A target the chromatin structure and histone modification processes, which are crucial for transcriptional regulation. By altering the chromatin landscape, these compounds can indirectly affect the transcription of ribosomal RNA genes, where TAF1D plays a significant role.

Moreover, the use of inhibitors like DRB, which targets RNA polymerase II, and C646, a p300/CBP histone acetyltransferase inhibitor, reflects the complex interplay between different transcriptional processes and the potential for cross-talk between RNA polymerase complexes. BIX-01294 and MLL1 inhibitors further expand this class by targeting histone methyltransferases, indicating the diverse mechanisms through which transcriptional regulation can be modulated, thereby indirectly influencing TAF1D's activity.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$88.00
$200.00
13
(1)

Triptolide is a diterpene triepoxide known to inhibit RNA polymerase I, potentially affecting TAF1D's function indirectly.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

Actinomycin D intercalates into DNA and inhibits RNA polymerase, which could indirectly influence TAF1D's activity.

CX-5461

1138549-36-6sc-507275
5 mg
$240.00
(0)

CX-5461 selectively inhibits RNA polymerase I transcription initiation, potentially impacting TAF1D activity.

BMH-21

896705-16-1sc-507460
10 mg
$165.00
(0)

BMH-21 binds to RNA polymerase I and disrupts its transcriptional activity, indirectly affecting TAF1D.

DRB

53-85-0sc-200581
sc-200581A
sc-200581B
sc-200581C
10 mg
50 mg
100 mg
250 mg
$42.00
$185.00
$310.00
$650.00
6
(1)

DRB inhibits RNA polymerase II, potentially altering transcriptional programs that indirectly affect TAF1D.

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
$226.00
$846.00
1
(0)

JQ1, a BET bromodomain inhibitor, modulates transcription and could indirectly influence TAF1D's role in RNA polymerase I transcription.

RGFP966

1357389-11-7sc-507300
5 mg
$115.00
(0)

RGFP966, an HDAC3 inhibitor, can affect chromatin state and thereby indirectly influence transcription activities related to TAF1D.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$130.00
$270.00
37
(2)

Vorinostat, an HDAC inhibitor, may indirectly affect TAF1D's function by altering chromatin structure and transcription.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

Trichostatin A, another HDAC inhibitor, could indirectly influence TAF1D through changes in chromatin dynamics and transcription.

C646

328968-36-1sc-364452
sc-364452A
10 mg
50 mg
$260.00
$925.00
5
(1)

C646 is a p300/CBP histone acetyltransferase inhibitor that could indirectly affect transcription processes involving TAF1D.